- Home
- Companies
- usa maryland
- nanoparticle
Refine by
Nanoparticle Suppliers In Usa Maryland
5 companies found
based inGaithersburg, MARYLAND (USA)
NexImmune is a clinical-stage biotechnology company developing unique approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation (AIMâ„¢) technology. AIM nanoparticles act as synthetic dendritic cells to deliver ...
The injectable modality (AIM INJ) is an injectable pharmaceutical product of AIM nanoparticles decorated with antigen-specific peptides and co-stimulatory molecules appropriate for the disease being targeted. Based on specific size ...
based inFrederick, MARYLAND (USA)
RoosterBio, Inc. is radically simplifying the use of adult human mesenchymal stem/stromal cells (hMSCs) to propel the commercialization of regenerative technologies. RoosterBio is enabling living cellular technologies to become more affordable, ...
Exosomes / Extracellular Vesicles (EVs) are an emerging class of biologics that play a crucial role in intercellular communication and hold tremendous promise for therapeutic and diagnostic use. A key challenge in the clinical translation of ...
based inColumbia, MARYLAND (USA)
Shimadzu Scientific Instruments (SSI) is the American subsidiary of Shimadzu Corporation, headquartered in Kyoto, Japan. Shimadzu is a $3 billion multinational corporation with three major divisions: Medical Diagnostics, Aerospace/industrial, and ...
based inRockville, MARYLAND (USA)
Weinberg Medical Physics has operated over the past 8 years as a medical device incubator developing novel medical imaging and interventional technologies that mature into self-sustaining start-ups. Our ultra-fast MRIs can provide rapid ...
based inGaithersburg, MARYLAND (USA)
We are a biotechnology company that promotes improved health globally through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases. We have more than a decade of experience contending with ...
In March 2020, we announced positive top-line results from our Phase 3 clinical trial of our nanoparticle seasonal quadrivalent influenza vaccine candidate, including our proprietary Matrix-M™ adjuvant (NanoFlu™). The ...